PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · IEX Real-Time Price · USD
1.570
-0.010 (-0.63%)
Jul 2, 2024, 4:00 PM EDT - Market closed
PMV Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for PMV Pharmaceuticals stock have an average target of 5.75, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 266.24% from the current stock price of 1.57.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for PMVP stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +218.47% | May 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +218.47% | May 14, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +282.17% | May 13, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +218.47% | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +218.47% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.40
from -1.44
EPS Next Year
-1.60
from -1.40
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 12.3M | 49.6M | 116.5M |
| Avg | n/a | n/a | 4.0M | 36.7M | 85.6M |
| Low | n/a | n/a | n/a | 30.8M | 52.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,147.0% | 217.3% |
| Avg | - | - | - | 823.0% | 133.0% |
| Low | - | - | - | 675.0% | 44.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.27 | -1.08 | -1.25 | -1.49 | -0.90 |
| Avg | -1.40 | -1.60 | -1.57 | -1.45 | -0.88 |
| Low | -1.52 | -1.93 | -1.91 | -1.39 | -0.84 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.